Form 4 Filing for OKYO Pharma Ltd

This filing details a transaction by Rajkumar V. Patil, Chief Scientific Officer of OKYO Pharma Ltd. On July 27, 2026, Mr. Patil acquired 3,363 shares of common stock at a price of $1.49 per share. Following this transaction, Mr. Patil now owns 20,030 shares of common stock. The transaction was reported on July 29, 2026. Mr. Patil is an officer of the company, and this transaction is directly held. The filing is a Form 4, indicating a change in beneficial ownership.